SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

3SBio, Inc. (SSRX)

SSRX RSS Feed
Add SSRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/24/2013 12:23:34 PM - Followers: 1 - Board type: Free - Posts Today: 0

http://bbs.3sbio.com/en/Index.aspx

http://finance.yahoo.com/q/ks?s=SSRX

http://moneycentral.msn.com/ownership?Symbol=SSRX


3SBio, Inc., a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the People's Republic of China. Its product candidates are designed to address unmet medical needs in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company's principal product, EPIAO is an injectable recombinant human erythropoietin that is used to stimulate the production of red blood cells in patients with anemia and to reduce the need for blood transfusions. It also offers TPIAO, a recombinant human thrombopoietin indicated for the treatment of chemotherapy-induced thrombocytopenia, a deficiency of platelets. In addition, the company markets two protein-based therapeutics, Intefen, a recombinant interferon alpha-2a product indicated for the treatment of carcinoma of the lymphatic or hematopoietic system and viral infectious diseases; and Inleusin, a recombinant human interleukin-2 product indicated for the treatment of renal cell carcinoma, metastatic melanoma, thoratic fluid build-up caused by cancer, and tuberculosis. Further, the company's product pipeline includes various protein-based therapeutics, including NuPIAO, a second-generation EPIAO product candidate; TPIAO for the treatment of idiopathic thrombocytopenic purpura; NuLeusin, a next-generation Inleusin product candidate; a human papilloma virus vaccine for the prevention of cervical cancer; and an anti-TNF humanized monoclonal antibody product candidate for the treatment of rheumatoid arthritis and other autoimmune diseases. 3SBio sells its products through a network of distributors to healthcare providers, including hospitals, clinics, and dialysis centers. It also markets its products through distribution agreements with local agents in various developing countries. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.



SureTrader
Interactive Brokers Advertisement
SSRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PostSubject
#73   11:54AM 3SBIO enters into amendment to merger agreement surf1944 04/24/13 12:23:34 PM
#72   5:32AM 3SBIO enters into merger agreement for 'going surf1944 02/08/13 08:47:29 AM
#71   3SBio Inc. (SSRX): Engages in the research, development, surf1944 02/05/13 09:18:25 AM
#70   SSRX more of a sale than a hold surf1944 12/05/12 01:52:04 PM
#69   8:02AM 3SBIO Announces Receipt of 'Going Private' Proposal surf1944 09/12/12 12:01:27 PM
#68   4:08AM 3SBIO beats by $0.05, beats on revs; surf1944 08/15/12 11:53:02 AM
#67   3SBIO SSRX HSBC Securities Overweight $20 » $17.60 surf1944 07/13/12 08:27:33 AM
#66   8:35AM 3SBIO obtains SFDA approval to join global surf1944 06/28/12 10:28:47 AM
#65   I bought SSRX last week based on its blasher 05/14/12 03:22:22 PM
#64   3SBio Inc. Files Annual Report on Form 20-F surf1944 05/13/12 04:50:31 PM
#63   4:02PM 3SBIO announced a collaboration agreement with DaVita surf1944 03/09/12 01:47:19 AM
#62   3SBio Inc. to Present at the UBS Greater surf1944 01/10/12 12:33:23 PM
#61   3SBio Inc. Schedules Unaudited Third Quarter 2011 Results surf1944 10/22/11 01:46:42 PM
#60   3SBio initiated with an Outperform at Cowen surf1944 09/03/11 05:01:09 PM
#59   1:39AM 3SBIO receives SFDA approval of High-Dose EPIAO surf1944 07/12/11 08:41:31 AM
#58   http://www.nasdaq.com/asp/holdings.asp?symbol=SSRX&selected=SSRX&FormType=Instit surf1944 06/29/11 06:53:04 AM
#57   3SBio Inc. (SSRX) surf1944 05/12/11 08:55:12 AM
#56   2:18AM 3SBIO misses by $0.03; beats on revs; surf1944 05/12/11 08:53:42 AM
#55   3SBIO SSRX Oppenheimer Outperform $17.50 » $21 surf1944 04/28/11 09:19:24 AM
#54   2:15AM 3SBIO misses by $0.01; beats on revs; surf1944 03/16/11 10:47:49 AM
#53   1:21AM 3SBIO announces partial conversion of Isotechnika Debenture surf1944 09/15/10 07:58:33 AM
#52   7:05AM 3SBIO and Isotechnika Pharma announce strategic partnership surf1944 08/24/10 08:25:27 AM
#51   3SBio and Isotechnika Pharma Announce Strategic Partnership to surf1944 08/24/10 07:34:28 AM
#50   3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results surf1944 08/06/10 09:05:11 AM
#49   http://finance.yahoo.com/q/is?s=ssrx&annual surf1944 07/12/10 01:23:25 PM
#48   3SBio Inc. Announces Unaudited First Quarter 2010 Results surf1944 05/17/10 09:16:12 AM
#47   3SBio Inc. To Report 2010 First Quarter Unaudited surf1944 05/11/10 09:57:54 AM
#46   Piper Jaffray reiterated Overweight rating and $16 price surf1944 05/03/10 12:29:54 PM
#45   http://finance.aol.com/company/3sbio-inc-american-depositary-shares/ssrx/nas/ins surf1944 03/27/10 12:54:18 PM
#44   3SBio and Ascentage Pharma Form Strategic Alliance to surf1944 02/11/10 09:22:19 PM
#43   3SBio Gains China Rights to Another Dialysis Drug surf1944 02/09/10 09:26:03 AM
#42   6:19AM 3SBIO and Panacor Bioscience enter collaboration and surf1944 02/08/10 07:44:45 AM
#41   3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) surf1944 01/14/10 01:09:46 PM
#40   3SBio Inc. Announces Unaudited Third Quarter 2009 Results surf1944 11/13/09 08:27:37 AM
#39   http://finance.aol.com/company/3sbio-inc-american-depositary-shares/ssrx/nas/institutional-ownership surf1944 10/04/09 10:18:16 PM
#37   http://www.mffais.com/ssrx surf1944 08/11/09 06:38:57 PM
#36   3SBio Inc. Announces Unaudited Second Quarter 2009 Results surf1944 08/11/09 06:37:43 PM
#35   3SBio Inc. to Report 2009 Second Quarter Earnings surf1944 07/31/09 09:47:21 AM
#34   3SBio Inc. Announces Appointment of Ernst & Young surf1944 05/05/09 08:47:43 AM
#33   China Bio in Review: More Fallout from Economic surf1944 11/09/08 09:50:57 PM
#32   3SBio Inc. Announces Results of Annual General Meeting surf1944 09/15/08 11:34:22 AM
#31   3SBio Inc. Q2 2008 Earnings Call Transcript surf1944 08/13/08 10:05:10 PM
#30   China Stocks: Top Ten by PEG surf1944 07/11/08 11:16:18 AM
#29   3SBio Inc. Announces Filing of Annual Report on surf1944 07/01/08 09:37:43 AM
#28   3SBio to Commercialize Iron Deficiency Agent in China surf1944 05/28/08 12:41:23 PM
#27   AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic surf1944 05/27/08 08:42:34 AM
#26   China Biopharma Growth Metrics surf1944 05/19/08 08:00:35 AM
#25   3SBio’s Q1: Revenues Rise, Net Income Lags surf1944 05/16/08 08:53:18 AM
#24   3SBio Inc. Schedules 2008 First Quarter Earnings Release surf1944 05/09/08 10:04:39 AM
#23   3SBio Inc. Approves Share Repurchase Program surf1944 03/19/08 04:33:55 PM
PostSubject